Retrieve available abstracts of 90 articles: HTML format
Single Articles
June 2025
WOLFE GI, Shelly S Myasthenia Gravis - Redemption for B-Cell Depletion.
N Engl J Med. 2025;392:2382-2384. PubMed
ZHANG L, Gao Z, Pan H, Li R, et al BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR
T-Cell Therapy.
N Engl J Med. 2025;392:2282-2284. PubMed
May 2025
KOSTER MJ, Warrington KJ Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis.
N Engl J Med. 2025;392:2062-2064. PubMed
BARRATT J, Perkovic V, Rizk DV Alternative Complement Pathway, Iptacopan, and IgA Nephropathy. Reply.
N Engl J Med. 2025;392:1976. PubMed
ANGELETTI A, Marasa M, Cravedi P Alternative Complement Pathway, Iptacopan, and IgA Nephropathy.
N Engl J Med. 2025;392:1976. PubMed
POPPELAARS F, Faria B, Thurman JM Alternative Complement Pathway, Iptacopan, and IgA Nephropathy.
N Engl J Med. 2025;392:1975. PubMed
CALABRESI PA Progress toward Mitigating Disability Progression in Multiple Sclerosis.
N Engl J Med. 2025;392:1966-1968. PubMed
HOSHINO Y, Okamoto K, Ito N More on Acquired Osteomalacia and Autoantibodies against PHEX. Reply.
N Engl J Med. 2025;392:1871-1872. PubMed
MINISOLA S, Pepe J, Cipriani C More on Acquired Osteomalacia and Autoantibodies against PHEX.
N Engl J Med. 2025;392:1871. PubMed
April 2025
FAVA A To B or Not to B - the Role of B-Cell Depletion in Lupus Nephritis.
N Engl J Med. 2025;392:1545-1547. PubMed
FOX RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, et al Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis.
N Engl J Med. 2025 Apr 8. doi: 10.1056/NEJMoa2415988. PubMedAbstract available
OH J, Arnold DL, Cree BAC, Ionete C, et al Tolebrutinib versus Teriflunomide in Relapsing Multiple Sclerosis.
N Engl J Med. 2025 Apr 8. doi: 10.1056/NEJMoa2415985. PubMedAbstract available
NOWAK RJ, Benatar M, Ciafaloni E, Howard JF Jr, et al A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis.
N Engl J Med. 2025 Apr 8. doi: 10.1056/NEJMoa2501561. PubMedAbstract available
BLOCKMANS D, Penn SK, Setty AR, Schmidt WA, et al A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis.
N Engl J Med. 2025 Apr 2. doi: 10.1056/NEJMoa2413449. PubMedAbstract available
March 2025
STONE JH, Khosroshahi A, Zhang W, Della Torre E, et al Inebilizumab for Treatment of IgG4-Related Disease.
N Engl J Med. 2025;392:1168-1177. PubMedAbstract available
February 2025
WANG JJ, Warkentin TE, Schonborn L, Wheeler MB, et al VITT-like Monoclonal Gammopathy of Thrombotic Significance.
N Engl J Med. 2025 Feb 12. doi: 10.1056/NEJMoa2415930. PubMedAbstract available
FURIE RA, Rovin BH, Garg JP, Santiago MB, et al Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis.
N Engl J Med. 2025 Feb 7. doi: 10.1056/NEJMoa2410965. PubMedAbstract available
January 2025
HOSHINO Y, Okamoto K, Ogawa T, Kato H, et al Acquired Osteomalacia Associated with Autoantibodies against PHEX.
N Engl J Med. 2025;392:513-515. PubMed
October 2024
PERKOVIC V, Barratt J, Rovin B, Kashihara N, et al Alternative Complement Pathway Inhibition with Iptacopan in IgA Nephropathy.
N Engl J Med. 2024 Oct 25. doi: 10.1056/NEJMoa2410316. PubMedAbstract available
INGELFINGER JR Way Stations in Progress - Burgeoning Treatment Options for IgA Nephropathy.
N Engl J Med. 2024 Oct 25. doi: 10.1056/NEJMe2413288. PubMed
HEERSPINK HJL, Jardine M, Kohan DE, Lafayette RA, et al Atrasentan in Patients with IgA Nephropathy.
N Engl J Med. 2024 Oct 25. doi: 10.1056/NEJMoa2409415. PubMedAbstract available
CHANTRAPITAK J, Chuamanochan M Intertriginous Rash in Secondary Syphilis.
N Engl J Med. 2024;391:e28. PubMed
TOMAS NM, Hengel FE, Huber TB Autoantibodies Targeting Nephrin in Podocytopathies. Reply.
N Engl J Med. 2024;391:1367-1368. PubMed
BRUSCHI M, Angeletti A, Ghiggeri GM Autoantibodies Targeting Nephrin in Podocytopathies.
N Engl J Med. 2024;391:1366. PubMed
BERG AH, Karumanchi SA Autoantibodies Targeting Nephrin in Podocytopathies.
N Engl J Med. 2024;391:1365-1366. PubMed
GLEESON PJ, Monteiro RC Autoantibodies Targeting Nephrin in Podocytopathies.
N Engl J Med. 2024;391:1365. PubMed
September 2024
RUSSO G, Alipour Tehrany Y Discoid Lupus Erythematosus.
N Engl J Med. 2024;391:e24. PubMed
SALVARANI C, Hunder GG, Brown RD Jr Primary Central Nervous System Vasculitis.
N Engl J Med. 2024;391:1028-1037. PubMed
HAGEN M, Bucci L, Boltz S, Nothling DM, et al BCMA-Targeted T-Cell-Engager Therapy for Autoimmune Disease.
N Engl J Med. 2024;391:867-869. PubMed
ALEXANDER T, Kronke J, Cheng Q, Keller U, et al Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus.
N Engl J Med. 2024;391:864-866. PubMed
August 2024
GRIFFIN H, Ceron-Gutierrez L, Gharahdaghi N, Ebrahimi S, et al Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
N Engl J Med. 2024;391:434-441. PubMedAbstract available
July 2024
LI M, Zhang Y, Jiang N, Ning C, et al Anti-CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE.
N Engl J Med. 2024;391:376-378. PubMed
WANG WY, Lin MC Chilblain Lupus Erythematosus.
N Engl J Med. 2024;391:e6. PubMed
CHENG A, Holland SM Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency. Reply.
N Engl J Med. 2024;391:189-190. PubMed
ROSMARIN D, Amara S, Lebwohl M Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
N Engl J Med. 2024;391:189. PubMed
COHEN JM, Damsky W Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
N Engl J Med. 2024;391:188-189. PubMed
FEREDJ E, Cobat A, Casanova JL Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
N Engl J Med. 2024;391:187-188. PubMed
June 2024
MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH Prevention of Cardiovascular Disease in Type 1 Diabetes. Reply.
N Engl J Med. 2024;390:2227. PubMed
MAAHS DM, Svensson J Prevention of Cardiovascular Disease in Type 1 Diabetes.
N Engl J Med. 2024;390:2226-2227. PubMed
WENSTEDT EFE, Vogt L Prevention of Cardiovascular Disease in Type 1 Diabetes.
N Engl J Med. 2024;390:2226. PubMed
CHEN Y, Xu Y, Li H, Sun T, et al A Novel Anti-CD38 Monoclonal Antibody for Treating Immune Thrombocytopenia.
N Engl J Med. 2024;390:2178-2190. PubMedAbstract available
May 2024
WECHSLER ME, Fan Y, Merkel PA Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with
Polyangiitis. Reply.
N Engl J Med. 2024;390:1940. PubMed
SUN R, Wei LJ Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with
Polyangiitis.
N Engl J Med. 2024;390:1939. PubMed
OIKONOMOU V, Smith G, Constantine GM, Schmitt MM, et al The Role of Interferon-gamma in Autoimmune Polyendocrine Syndrome Type 1.
N Engl J Med. 2024;390:1873-1884. PubMedAbstract available
SU MA JAK Inhibition Immunotherapy for APS-1.
N Engl J Med. 2024;390:1918-1921. PubMed
HENGEL FE, Dehde S, Lasse M, Zahner G, et al Autoantibodies Targeting Nephrin in Podocytopathies.
N Engl J Med. 2024 May 25. doi: 10.1056/NEJMoa2314471. PubMedAbstract available
WANG JJ, Schonborn L, Warkentin TE, Chataway T, et al Antibody Fingerprints Linking Adenoviral Anti-PF4 Disorders.
N Engl J Med. 2024;390:1827-1829. PubMed
DOUGHTY CT, Schaefer PW, Brizzi K, Linnoila JJ, et al Case 14-2024: A 30-Year-Old Woman with Back Pain, Leg Stiffness, and Falls.
N Engl J Med. 2024;390:1712-1719. PubMed
MULLER F, Mackensen A, Schett G CAR T-Cell Therapy in Autoimmune Disease. Reply.
N Engl J Med. 2024;390:1631-1632. PubMed
HOWARD JF JR, Vu T, Mozaffar T CAR T-Cell Therapy in Autoimmune Disease.
N Engl J Med. 2024;390:1629-1631. PubMed
DE BENEDETTI F, Diomedi Camassei F, Locatelli F CAR T-Cell Therapy in Autoimmune Disease.
N Engl J Med. 2024;390:1629. PubMed
MERKT W, Lorenz HM, Schmitt M CAR T-Cell Therapy in Autoimmune Disease.
N Engl J Med. 2024;390:1628-1629. PubMed
April 2024
MATHUR M, Barratt J, Suzuki Y Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy. Reply.
N Engl J Med. 2024;390:1245-1246. PubMed
BELMONT HM Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
N Engl J Med. 2024;390:1245. PubMed
MANRIQUE-ACEVEDO C, Hirsch IB, Eckel RH Prevention of Cardiovascular Disease in Type 1 Diabetes.
N Engl J Med. 2024;390:1207-1217. PubMed
March 2024
NETEA MG, van de Veerdonk FL Anti-Interleukin-23 Autoantibodies and Severe Infections.
N Engl J Med. 2024;390:1143-1146. PubMed
CHENG A, Kashyap A, Salvator H, Rosen LB, et al Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
N Engl J Med. 2024;390:1105-1117. PubMedAbstract available
DRIVENES JL, Bygum A Spontaneous Oral Purpura in Immune Thrombocytopenia.
N Engl J Med. 2024;390:1029. PubMed
WECHSLER ME, Nair P, Terrier B, Walz B, et al Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with
Polyangiitis.
N Engl J Med. 2024;390:911-921. PubMedAbstract available
February 2024
MULLER F, Taubmann J, Bucci L, Wilhelm A, et al CD19 CAR T-Cell Therapy in Autoimmune Disease - A Case Series with Follow-up.
N Engl J Med. 2024;390:687-700. PubMedAbstract available
ISAACS JD CAR T Cells - A New Horizon for Autoimmunity?
N Engl J Med. 2024;390:758-759. PubMed
HAUSER SL Silencing Immune Dialogue in Multiple Sclerosis.
N Engl J Med. 2024;390:662-663. PubMed
VERMERSCH P, Granziera C, Mao-Draayer Y, Cutter G, et al Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
N Engl J Med. 2024;390:589-600. PubMedAbstract available
January 2024
DANDONA P, Chaudhuri A, Ghanim H More on Semaglutide in Early Type 1 Diabetes. Reply.
N Engl J Med. 2024;390:292. PubMed
GAGLIA JL, Laffel LM, Patti ME More on Semaglutide in Early Type 1 Diabetes.
N Engl J Med. 2024;390:291. PubMed
WEINRAUCH LA, D'Elia JA More on Semaglutide in Early Type 1 Diabetes.
N Engl J Med. 2024;390:291. PubMed
DEVRIES JH More on Semaglutide in Early Type 1 Diabetes.
N Engl J Med. 2024;390:290. PubMed
HADZIC N, Deheragoda M, Worth A, Bansal S, et al JAK Inhibition in STAT1 Gain-of-Function-Mediated Treatment-Resistant Autoimmune
Hepatitis.
N Engl J Med. 2024;390:284-286. PubMed
LEE TTM, Bergford S, Murphy HR Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
Reply.
N Engl J Med. 2024;390:184. PubMed
GRZYCH G, Kim I Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
N Engl J Med. 2024;390:183-184. PubMed
VIVANTI AJ, Benachi A, Voican A Automated Insulin Delivery during Pregnancy Complicated by Type 1 Diabetes.
N Engl J Med. 2024;390:183. PubMed
LEMLEY KV, Glassock RJ APRIL - Springtime for New IgA Nephropathy Therapy?
N Engl J Med. 2024;390:80-81. PubMed
LIU MJ, Li J Necrobiosis Lipoidica.
N Engl J Med. 2024;390:70. PubMed
December 2023
ARJUNAN D, Bhadada SK Thyroid Dermopathy in Graves' Disease.
N Engl J Med. 2023;389:2376. PubMed
LUDVIGSSON J Immune Interventions at Onset of Type 1 Diabetes - Finally, a Bit of Hope.
N Engl J Med. 2023;389:2199-2201. PubMed
WAIBEL M, Wentworth JM, So M, Couper JJ, et al Baricitinib and beta-Cell Function in Patients with New-Onset Type 1 Diabetes.
N Engl J Med. 2023;389:2140-2150. PubMedAbstract available
BUSSEL JB, Hou M, Cines DB Primary Immune Thrombocytopenia in Pregnancy. Reply.
N Engl J Med. 2023;389:1728. PubMed
TRAN BW, May KA, Pal N Primary Immune Thrombocytopenia in Pregnancy.
N Engl J Med. 2023;389:1728. PubMed
MATHUR M, Barratt J, Chacko B, Chan TM, et al A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.
N Engl J Med. 2023 Nov 2. doi: 10.1056/NEJMoa2305635. PubMedAbstract available
October 2023
RAMOS EL, Dayan CM, Chatenoud L, Sumnik Z, et al Teplizumab and beta-Cell Function in Newly Diagnosed Type 1 Diabetes.
N Engl J Med. 2023 Oct 18. doi: 10.1056/NEJMoa2308743. PubMedAbstract available
LINDHOFF-LAST E, Schonborn L, Zaninetti C, Warkentin TE, et al Rescue Therapy in Chronic Prothrombotic Autoimmune Anti-PF4 Disorder.
N Engl J Med. 2023;389:1339-1341. PubMed
SPIERA RF, Unizony S, Warrington KJ, Sloane J, et al Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.
N Engl J Med. 2023;389:1263-1272. PubMedAbstract available
LEE TTM, Collett C, Bergford S, Hartnell S, et al Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1
Diabetes.
N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMoa2303911. PubMedAbstract available
GARG SK, Polsky S Technology Use and Glycemic Outcomes during Pregnancy with Type 1 Diabetes.
N Engl J Med. 2023 Oct 5. doi: 10.1056/NEJMe2310798. PubMed
ALETAHA D Polymyalgia Rheumatica - from Search for Efficacy to Choice of Strategy.
N Engl J Med. 2023;389:1328-1329. PubMed
September 2023
BRODERICK L, Kastner DL Variant STAT4 and Treatment of an Autoinflammatory Syndrome. Reply.
N Engl J Med. 2023;389:1151-1152. PubMed
PASTORE S, De Martino E, Taddio A Variant STAT4 and Treatment of an Autoinflammatory Syndrome.
N Engl J Med. 2023;389:1151. PubMed
WANG WY, Cheng ST Sleeve Sign and Inverse Gottron's Papules in Anti-MDA5 Dermatomyositis.
N Engl J Med. 2023;389:1032. PubMed
DANDONA P, Chaudhuri A, Ghanim H Semaglutide in Early Type 1 Diabetes.
N Engl J Med. 2023;389:958-959. PubMed